Faraz Ali - Net Worth and Insider Trading
Faraz Ali Net Worth
The estimated net worth of Faraz Ali is at least $303,213 dollars as of 2024-12-27. Faraz Ali is the CEO of Tenaya Therapeutics Inc and owns about 188,331 shares of Tenaya Therapeutics Inc (TNYA) stock worth over $303,213. Details can be seen in Faraz Ali's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Faraz Ali has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Faraz Ali
Faraz Ali Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Faraz Ali owns 2 companies in total, including Regenxbio Inc (RGNX) , and Tenaya Therapeutics Inc (TNYA) .
Click here to see the complete history of Faraz Ali’s form 4 insider trades.
Insider Ownership Summary of Faraz Ali
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGNX | Regenxbio Inc | 2016-02-29 | Chief Business Officer |
| TNYA | Tenaya Therapeutics Inc | 2024-08-16 | director & Chief Executive Officer |
Faraz Ali Latest Holdings Summary
Faraz Ali currently owns a total of 1 stock. Faraz Ali owns 188,331 shares of Tenaya Therapeutics Inc (TNYA) as of August 16, 2024, with a value of $303,213.
Latest Holdings of Faraz Ali
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics Inc | 2024-08-16 | 188,331 | 1.61 | 303,213 |
Holding Weightings of Faraz Ali
Faraz Ali Form 4 Trading Tracker
According to the SEC Form 4 filings, Faraz Ali has made a total of 3 transactions in Tenaya Therapeutics Inc (TNYA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Tenaya Therapeutics Inc is the sale of 9,748 shares on August 16, 2024, which brought Faraz Ali around $28,172.
Insider Trading History of Faraz Ali
- 1
Faraz Ali Trading Performance
Faraz Ali Ownership Network
Faraz Ali Owned Company Details
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Faraz Ali is the Chief Business Officer of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Faraz Ali made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .
In summary, during the past 3 months, insiders sold 10,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
Faraz Ali Mailing Address
Above is the net worth, insider trading, and ownership report for Faraz Ali. You might contact Faraz Ali via mailing address: C/o Tenaya Therapeutics, Inc., 171 Oyster Point Blvd., 5th Flr., South San Francisco Z4 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
